Breaking News Instant updates and real-time market news.

WVE

Wave Life Sciences

$39.75

-0.2 (-0.50%)

08:08
08/09/18
08/09
08:08
08/09/18
08:08

Wave Life Sciences reports Q2 EPS ($2.49), consensus (55c)

Reports Q2 revenue $4.88M, consensus $21.38M. The increase in net loss in the second quarter of 2018 was largely driven by increased research and development efforts and the continued growth of employee headcount to support Wave's programs. Wave expects that its existing cash and cash equivalents, together with expected and committed cash from existing collaborations, will enable it to fund its operating and capital expenditure requirements to the end of 2020.

WVE Wave Life Sciences
$39.75

-0.2 (-0.50%)

08/07/18
STFL
08/07/18
INITIATION
Target $56
STFL
Buy
Wave Life Sciences initiated with a Buy at Stifel
Stifel analyst Paul Matteis initiated Wave Life Sciences (WVE) with a Buy rating and $56 price target, stating that he sees Takeda's (TKPYY) $170M upfront payment as validating to its platform and set of CNS candidates. Wave is one of his favorite names ahead of a catalyst-rich 12-18 months that includes proof-of-concept data in Huntington's in the first half of 2019, and safety and efficacy data for Wave's candidate in Duchenne, Matteis tells investors.
08/06/18
STFL
08/06/18
INITIATION
STFL
Buy
Wave Life Sciences initiated with a Buy at Stifel
07/23/18
HCWC
07/23/18
INITIATION
Target $49
HCWC
Buy
Wave Life Sciences assumed with a Buy at H.C. Wainwright
H.C. Wainwright analyst Debjit Chattopadhyay assumed coverage of Wave Life Sciences with a Buy rating and $49 price target. The analyst sees "significant upside" for the shares should the company's emerging clinical data hold up to scrutiny.
06/20/18
LEER
06/20/18
NO CHANGE
Target $55
LEER
Outperform
Micro-dystrophin data raises bar in DMD for Wave Life Sciences, says Leerink
Leerink analyst Geoffrey Porges notes that Sarepta (SRPT) hosted an R&D Day during which it presented data from three patients with Duchenne muscular dystrophy who have received treatment with their micro-dystrophin gene therapy. The results greatly exceeded expectations by demonstrating 38%-54% micro-dystrophin protein expression on Western Blot, he contends. Nonetheless, the analyst points out that he is limited to "patiently awaiting" further results from Sarepta's program in order to determine how exon-skipping oligonucleotides such as Wave Life Sciences' (WVE) WVE-210201 would be positioned in the maintenance post-gene therapy setting, or if the FDA will even accept micro-dystrophin expression as a regulatory endpoint for gene therapy. He reiterates an Outperform rating and $55 price target on Wave's shares.

TODAY'S FREE FLY STORIES

SNAP

Snap

$10.63

-0.31 (-2.83%)

06:57
03/20/19
03/20
06:57
03/20/19
06:57
Periodicals
Snapchat admits age verification process is effectively useless, BI reports »

Snap's senior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

ZEAL

Zealand Pharma

$15.60

(0.00%)

06:57
03/20/19
03/20
06:57
03/20/19
06:57
Hot Stocks
Breaking Hot Stocks news story on Zealand Pharma »

Zealand Pharma AS (ADS)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMAR

Smartsheet

$43.51

-0.16 (-0.37%)

06:57
03/20/19
03/20
06:57
03/20/19
06:57
Recommendations
Smartsheet analyst commentary  »

Smartsheet price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Apr

TXRH

Texas Roadhouse

$60.46

-0.39 (-0.64%)

06:56
03/20/19
03/20
06:56
03/20/19
06:56
Upgrade
Texas Roadhouse rating change  »

Texas Roadhouse upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAYRY

Bayer

$0.00

(0.00%)

, AZN

AstraZeneca

$42.87

0.29 (0.68%)

06:54
03/20/19
03/20
06:54
03/20/19
06:54
Recommendations
Bayer, AstraZeneca, Sanofi, Novartis, Merck analyst commentary  »

Bayer shares likely to…

BAYRY

Bayer

$0.00

(0.00%)

AZN

AstraZeneca

$42.87

0.29 (0.68%)

SNY

Sanofi

$45.18

0.27 (0.60%)

NVS

Novartis

$92.99

-0.205 (-0.22%)

MRK

Merck

$81.93

0.59 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 22

    Mar

  • 25

    Mar

  • 11

    Apr

  • 28

    Apr

  • 30

    Apr

  • 18

    May

  • 17

    Jun

BA

Boeing

$373.87

1.77 (0.48%)

06:51
03/20/19
03/20
06:51
03/20/19
06:51
Periodicals
Off-duty pilot saved Lion Air 737 day before fatal crash, Bloomberg reports »

An off-duty pilot…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    May

CTXS

Citrix

$101.31

-0.24 (-0.24%)

06:51
03/20/19
03/20
06:51
03/20/19
06:51
Conference/Events
Citrix to host CEMEX Day 2019 »

CEMEX Day 2019 to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 17

    Apr

IRM

Iron Mountain

$34.51

-0.29 (-0.83%)

06:51
03/20/19
03/20
06:51
03/20/19
06:51
Hot Stocks
Iron Mountain, MakeSpace announce partnership for storage services »

MakeSpace, an on-demand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$175.77

6.86 (4.06%)

06:49
03/20/19
03/20
06:49
03/20/19
06:49
Recommendations
Nvidia analyst commentary  »

Nvidia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKBA

Akebia

$8.12

-0.07 (-0.85%)

06:48
03/20/19
03/20
06:48
03/20/19
06:48
Initiation
Akebia initiated  »

Citi starts Akebia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JMP

JMP Group

$3.79

-0.07 (-1.81%)

06:48
03/20/19
03/20
06:48
03/20/19
06:48
Hot Stocks
JMP Group sells majority interest in JMP Credit Advisors »

JMP Group has sold a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$42.32

0.51 (1.22%)

06:47
03/20/19
03/20
06:47
03/20/19
06:47
Hot Stocks
Pfizer secures exclusive option to acquire Vivet Therapeutics »

Vivet Therapeutics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 30

    Apr

  • 18

    May

FDX

FedEx

$181.50

-0.92 (-0.50%)

06:46
03/20/19
03/20
06:46
03/20/19
06:46
Recommendations
FedEx analyst commentary  »

FedEx remains 'story…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Apr

  • 02

    Apr

  • 25

    Jun

ENV

Envestnet

$66.69

0.29 (0.44%)

06:45
03/20/19
03/20
06:45
03/20/19
06:45
Downgrade
Envestnet rating change  »

Envestnet downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

06:45
03/20/19
03/20
06:45
03/20/19
06:45
General news
Breaking General news story  »

Week of 3/15 MBA Mortgage…

ZTS

Zoetis

$98.72

0.95 (0.97%)

06:43
03/20/19
03/20
06:43
03/20/19
06:43
Initiation
Zoetis initiated  »

Zoetis resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TYL

Tyler Technologies

$204.57

0.855 (0.42%)

06:43
03/20/19
03/20
06:43
03/20/19
06:43
Conference/Events
Tyler Technologies management to meet with KeyBanc »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

MO

Altria Group

$56.01

-1.295 (-2.26%)

06:42
03/20/19
03/20
06:42
03/20/19
06:42
Periodicals
FDA commissioner calls meeting with Altria, Juul 'difficult', CNBC reports »

Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 16

    May

TDC

Teradata

$48.33

0.58 (1.21%)

06:42
03/20/19
03/20
06:42
03/20/19
06:42
Downgrade
Teradata rating change  »

Citi downgrades Teradata…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

STL

Sterling Bancorp

$19.86

-0.39 (-1.93%)

06:40
03/20/19
03/20
06:40
03/20/19
06:40
Conference/Events
Sterling Bancorp management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

  • 22

    Mar

  • 18

    Jun

  • 19

    Jun

ELAN

Elanco

$33.00

1.36 (4.30%)

, ZTS

Zoetis

$98.72

0.95 (0.97%)

06:39
03/20/19
03/20
06:39
03/20/19
06:39
Initiation
Elanco, Zoetis initiated  »

Elanco resumed with a…

ELAN

Elanco

$33.00

1.36 (4.30%)

ZTS

Zoetis

$98.72

0.95 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

ROK

Rockwell Automation

$178.71

-2.02 (-1.12%)

06:38
03/20/19
03/20
06:38
03/20/19
06:38
Downgrade
Rockwell Automation rating change  »

Rockwell Automation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIBN

SI-Bone

$19.00

-0.01 (-0.05%)

06:37
03/20/19
03/20
06:37
03/20/19
06:37
Conference/Events
SI-Bone management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

NOK

Nokia

$6.35

0.02 (0.32%)

06:36
03/20/19
03/20
06:36
03/20/19
06:36
Downgrade
Nokia rating change  »

Nokia downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

VOD

Vodafone

$19.22

0.13 (0.68%)

06:36
03/20/19
03/20
06:36
03/20/19
06:36
Upgrade
Vodafone rating change  »

Vodafone upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.